AAAAAA

   
Results: 1-12 |
Results: 12
Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using human normal and neoplastic skin cell lines
Authors: Finn, GJ Creaven, B Egan, DA
Citation: Gj. Finn et al., Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using human normal and neoplastic skin cell lines, MELANOMA RE, 11(5), 2001, pp. 461-467
Untitled
Authors: Egan, DA
Citation: Da. Egan, Untitled, SPINE, 25(21), 2000, pp. 2845-2846
The measurement of static pelvic skeletal asymmetry
Authors: Egan, DA
Citation: Da. Egan, The measurement of static pelvic skeletal asymmetry, SPINE, 25(19), 2000, pp. 2551-2552
Compliance to multiple interventions in a high risk population
Authors: Pettinger, MB Waclawiw, MA Davis, KB Thomason, T Garg, R Griffin, B Egan, DA
Citation: Mb. Pettinger et al., Compliance to multiple interventions in a high risk population, ANN EPIDEMI, 9(7), 1999, pp. 408-418
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
Authors: Torii, S Egan, DA Evans, RA Reed, JC
Citation: S. Torii et al., Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs), EMBO J, 18(21), 1999, pp. 6037-6049
Molecular genetics of acute promyelocytic leukemia
Authors: Lin, RJ Egan, DA Evans, RM
Citation: Rj. Lin et al., Molecular genetics of acute promyelocytic leukemia, TRENDS GEN, 15(5), 1999, pp. 179-184
Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
Authors: Doucas, V Tini, M Egan, DA Evans, RM
Citation: V. Doucas et al., Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling, P NAS US, 96(6), 1999, pp. 2627-2632
Target acquisition and acute promyelocytic leukemia
Authors: Egan, DA Evans, RM
Citation: Da. Egan et Rm. Evans, Target acquisition and acute promyelocytic leukemia, J CLIN INV, 103(10), 1999, pp. 1367-1368
Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study
Authors: Egan, DA Garg, R Wilt, TJ Pettinger, MB Davis, KB Crouse, J Herd, JA Hunninghake, DB Sheps, DS Kostis, JB Probstfield, J Waclawiw, MA Applegate, W Elam, MB
Citation: Da. Egan et al., Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study, AM J CARD, 83(4), 1999, pp. 569-575
Domain structure analysis of elongation factor-3 from Saccharomyces cerevisiae by limited proteolysis and differential scanning calorimetry
Authors: Ladror, US Egan, DA Snyder, SW Capobianco, JO Goldman, RC Dorwin, SA Johnson, RW Edalji, R Sarthy, AV McGonigal, T Walter, KA Holzman, TF
Citation: Us. Ladror et al., Domain structure analysis of elongation factor-3 from Saccharomyces cerevisiae by limited proteolysis and differential scanning calorimetry, PROTEIN SCI, 7(12), 1998, pp. 2595-2601
Transcriptional regulation of MDR genes
Authors: Scotto, KW Egan, DA
Citation: Kw. Scotto et Da. Egan, Transcriptional regulation of MDR genes, CYTOTECHNOL, 27(1-3), 1998, pp. 257-269
Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 angstrom
Authors: Bussiere, DE Kong, XP Egan, DA Walter, K Holzman, TF Lindh, F Robins, T Giranda, VL
Citation: De. Bussiere et al., Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 angstrom, ACT CRYST D, 54, 1998, pp. 1367-1376
Risultati: 1-12 |